BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30132562)

  • 1. Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
    Sumita Y; Yamazaki M; Maruyama S; Abé T; Cheng J; Takagi R; Tanuma JI
    Oncol Rep; 2018 Nov; 40(5):2487-2496. PubMed ID: 30132562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
    Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
    BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
    J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma.
    Lin CY; Jeng YM; Chou HY; Hsu HC; Yuan RH; Chiang CP; Kuo MY
    J Surg Oncol; 2008 May; 97(6):544-50. PubMed ID: 18297688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis.
    Okada S; Irié T; Tanaka J; Yasuhara R; Yamamoto G; Isobe T; Hokazono C; Tachikawa T; Kohno Y; Mishima K
    J Oral Pathol Med; 2015 Feb; 44(2):115-25. PubMed ID: 25060351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma.
    Kawasaki M; Sakabe T; Kodani I; Umekita Y
    Anticancer Res; 2021 Sep; 41(9):4563-4570. PubMed ID: 34475084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.
    Mikami T; Hada T; Chosa N; Ishisaki A; Mizuki H; Takeda Y
    J Oral Pathol Med; 2013 Feb; 42(2):133-9. PubMed ID: 22672247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased cytoplasmic X-box binding protein-1 expression is associated with poor prognosis and overall survival in patients with oral squamous cell carcinoma.
    Hsu HT; Hsing MT; Yeh CM; Chen CJ; Yang JS; Yeh KT
    Clin Chim Acta; 2018 Apr; 479():66-71. PubMed ID: 29305191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.
    Kumar M; Mehra S; Thakar A; Shukla NK; Roychoudhary A; Sharma MC; Ralhan R; Chauhan SS
    Clin Chim Acta; 2016 Aug; 459():45-52. PubMed ID: 27208742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
    Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M
    Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
    J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Lee JJ; Kok SH; Chou CH; Chang HH; Yang H; Chiang ML; Kuo MY
    J Formos Med Assoc; 2011 Jan; 110(1):50-7. PubMed ID: 21316013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.